Page last updated: 2024-08-26

lysophosphatidic acid and Acute Relapsing Multiple Sclerosis

lysophosphatidic acid has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, D; Ju, W; Wu, X; Zhan, X1
Balood, M; Harirchian, MH; Mesbah-Namin, SA; Siroos, B; Torbati, S; Zahednasab, H1

Other Studies

2 other study(ies) available for lysophosphatidic acid and Acute Relapsing Multiple Sclerosis

ArticleYear
Elevated lysophosphatidic acid levels in the serum and cerebrospinal fluid in patients with multiple sclerosis: therapeutic response and clinical implication.
    Neurological research, 2018, Volume: 40, Issue:5

    Topics: Adult; Biomarkers; Female; Glucocorticoids; Humans; Lysophospholipids; Male; Multiple Sclerosis, Relapsing-Remitting; Treatment Outcome

2018
Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.
    Human immunology, 2014, Volume: 75, Issue:5

    Topics: Adult; Female; Humans; Lysophospholipids; Male; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting

2014